Products
Clinical Settings
- Blood BanksIn a blood bank, protecting the donor and making the donation process as smooth and safe as possible is crucial. By using a point-of-care hemoglobin test, you can meet the changing needs while protecting the source.
- Public HealthBy providing access to accurate screening tools ideal for use even in field-settings, we help public health workers protect the children shaping our future.
- Hospital CareIn a hospital setting, time is of the essence. Whether detecting internal bleeding in a busy emergency department or monitoring a patient in the intensive care unit, you can benefit from access to immediate, lab-accurate results at the point of care.
- Primary CareWhen your clinic runs effectively, you have the freedom to provide the best care for your patients. HemoCue’s point-of-care testing systems enable quick and accurate results so that treatment decisions can be made with your patient still in the room.
Health Areas
- DiabetesReliable and accurate systems for screening, aiding in diagnosing and monitoring of diabetes are key for high quality patient care.
- InfectionsEffective point-of-care tools for infection screening giving you fast and accurate results, in combination with observations of a patient's symptoms, can support quick decision-making.
- AnemiaBy providing access to accurate screening tools, you can more easily detect those at risk. HemoCue’s point-of-care testing systems are portable and easy to use, even in remote settings.
Knowledge Center
- Knowledge Center
Our company
Contact
- Contact
- Technical support

Legal

Information about HemoCue intellectual property rights – trademarks and patents – and legal information regarding the use of hemocue.com

Patents

HemoCue products may be covered by one or more of the following patents, patent applications and designs.

HemoCue^® Hb 801 System

SE 542103; JP 6857287; AU 2018363712; CN 111447998; RCD 004500106-0001; US D870,315S; IN 305250; UKD 90045001060001

HemoCue^® Hb 301 System

RCD 000503230

HemoCue^® WBC System

US 7,521,243; US 8,092,758; EP 1701150; SE 500549; IN 250505; NO 340137; BR PI608340-4; ZL 200680007655.5; AU 2006221130; US 7,633,615; EP 2041581; SE 601576; AU 2007275925; ZL 200780026238.X; NO 340137; SE 700086; EP 1947441

HemoCue^® WBC DIFF System

US 7,521,243; US 8,092,758; EP 1701150; SE 500549; IN 250505; NO 340137; BR PI608340-4; ZL 200680007655.5; AU 2006221130; US 7,633,615; EP 2041581; SE 601576; AU 2007275925; ZL 200780026238.X; NO 340137; US 8,224,058; SE 601575; EP 2041549; SE 700958; AU 2007275927; ZL 200780026960.3; NO 343728; US 8,009,894; SE 800117; ZL 200980102032.X; IN 290425; JP 5129347